Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The CORE Study (Chemotherapy or Endocrine Treatment first?)
2005-000986-20Phase 3Completed
- Sponsor
- Technical University of Munich
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of letrozole in breast cancer (2 arms), sponsored by Technical University of Munich. Primary endpoint: overall survival. Started Aug 2005; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-000986-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000986-20.